Table 7.

Odds ratios (95% confidence intervals) of groups of mental disorders (lifetime prevalence) regressed on immune-mediated classes, men and women

	Neutral class	Resilient class	Atopic class	Mixed class	ACE class
Men
Neurodevelopmental disorders	1 (ref.)	0.8 (0.5–1.2)	1.7 (1.0–3.0)	2.0 (1.3–3.2)	4.0 (2.4–6.5)
Early anxiety disorders	1 (ref.)	0.8 (0.6–1.1)	1.1 (0.7–1.8)	2.0 (1.4–2.8)	2.7 (1.7–4.3)
Late anxiety disorders	1 (ref.)	0.7 (0.5–1.0)	1.2 (0.7–2.1)	1.5 (1.0–2.4)	1.6 (0.9–2.9)
Mood disorders	1 (ref.)	0.8 (0.7–1.0)	1.5 (1.0–2.2)	1.8 (1.3–2.5)	2.3 (1.5–3.4)
Substance disorders	1 (ref.)	0.9 (0.7–1.2)	1.1 (0.7–1.6)	1.1 (0.8–1.6)	1.8 (1.1–2.8)
Women
Neurodevelopmental disorders	1 (ref.)	0.6 (0.3–1.0)	0.9 (0.4–1.8)	1.6 (0.9–2.6)	3.8 (2.3–6.2)
Early anxiety disorders	1 (ref.)	0.7 (0.5–0.9)	1.6 (1.2–2.2)	1.4 (1.1–1.9)	3.0 (2.1–4.2)
Late anxiety disorders	1 (ref.)	0.8 (0.6–1.1)	1.2 (0.8–1.8)	1.6 (1.1–2.2)	2.7 (1.9–4.0)
Mood disorders	1 (ref.)	0.9 (0.7–1.0)	1.1 (0.8–1.5)	1.4 (1.1–1.9)	2.2 (1.5–3.2)
Substance disorders	1 (ref.)	0.6 (0.4–1.0)	1.8 (1.0–3.0)	1.6 (1.0–2.6)	2.7 (1.6–4.6)

ACE adverse childhood experiences

Groups of mental disorders: neurodevelopmental disorders—tics, attention-deficit hyperactivity disorder, conduct disorder, oppositional defiant disorder; early anxiety disorders—separation anxiety disorder, overanxious disorder, specific phobias (animals), social phobia; late anxiety disorders—generalized anxiety disorder, panic, agoraphobia, specific phobias (excl. animals); mood disorders—major depression disorder, dysthymia, bipolar disorders; substance disorders—alcohol, cannabis, other illicit drug abuse/dependence